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Abstract
In vitro models that capture the complexity of in vivo tissue and organ behaviors in a scalable and
easy-to-use format are desirable for drug discovery. To address this, we have developed a
bioreactor that fosters maintenance of 3D tissue cultures under constant perfusion and we have
integrated multiple bioreactors into an array in a multiwell plate format. All bioreactors are
fluidically isolated from each other. Each bioreactor in the array contains a scaffold that supports
formation of hundreds of 3D microscale tissue units. The tissue units are perfused with cell culture
medium circulated within the bioreactor by integrated pneumatic diaphragm micropumps.
Electronic controls for the pumps are kept outside the incubator and connected to the perfused
multiwell by pneumatic lines. The docking design and open-well bioreactor layout make handling
perfused multiwell plates similar to using standard multiwell tissue culture plates. A model of
oxygen consumption and transport in the circulating culture medium was used to predict
appropriate operating parameters for primary liver cultures. Oxygen concentrations at key
locations in the system were then measured as a function of flow rate and time after initiation of
culture to determine oxygen consumption rates. After seven days in culture, tissue formed from
cells seeded in the perfused multiwell reactor remained functionally viable as assessed by
immunostaining for hepatocyte and liver sinusoidal endothelial cell (LSEC) phenotypic markers.
Introduction
In vitro models of liver are an important tool in pharmaceutical drug development and in
understanding liver pathophysiology.1 Many biological responses in liver arise from
complex interactions between different cell types and vary with position along the capillary
bed.2, 3 Microfluidic platforms that recapitulate the physiological cellular microenvironment
of the hepatic capillary bed, with perfusion flow that allows development of physiological
oxygen gradients, may be useful in understanding liver toxicity, disease, inflammation, and
drug metabolism.4–14 Although many types of perfusion bioreactors for 3D culture have
been developed, they are generally limited in throughput and often complicated to use. The
approach reported in this paper adapts 3D models to an easy-to-use, multiwell plate format
suitable for higher throughput applications. Ease of use is achieved by designing the
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bioreactors as an array of open wells covered by a conventional tissue culture lid and by
employing docking stations that facilitate handling the perfused multiwell plates.
We describe the design and function of a perfused multiwell plate containing 12 fluidically
isolated bioreactors that each accommodate 400,000 – 600,000 cells. Perfusion of the tissue
is achieved by pneumatically actuated micropumps embedded in the plate. This type of
actuation was selected because it offers significant advantages for operation inside
humidified CO2 incubators maintained at 37 °C, a harsh environment for electrically driven
micropumps. Pneumatic actuation permits the necessary electronic timing components to be
kept outside the incubator. This arrangement can make perfused multiwell plates
inexpensive or even disposable if mass-produced. Additionally, life science research
laboratories in academia and industry typically have distributed outlets for vacuum and
compressed air which makes sources for pneumatic actuation readily available.
Three dimensional tissues cultures in the perfused multiwell system are initiated by pipetting
a cell suspension directly onto extracellular matrix (ECM)-coated scaffolds. Microscale
perfusion is started immediately after seeding to control the local oxygen concentration and
biomechanical stimuli (i.e., shear stress) during the critical time period of tissue formation.
This arrangement addresses some of the issues that have been reported in seeding microscale
perfusion systems such as seeding efficiencies and local control of oxygen during the initial
static incubation required for cell attachment.15–18
Oxygen is a key regulator of cell survival and function and thus, its level in cell culture
medium must be adequately controlled. We developed a model of oxygen transport and
reaction in our recirculating system and used it to predict oxygen concentration gradients
across the tissue and profiles in the bioreactor as a function of system parameters (e.g., flow
rate, flow direction, and medium volume). Finally, we demonstrate that this perfused
multiwell plate system is amenable to long-term maintenance of differentiated hepatocytes
and LSECs.
Experimental
Concept of perfused multiwell plates
The perfused multiwell is an array of open well bioreactors (Fig. 1a), each consisting of a
reactor well, a reservoir well, and an integrated micropump. The reactor well contains an
ECM-coated scaffold where cells self-assemble into an array of 3D microtissue units. The
reservoir well holds cell culture medium that is continually circulated between the two wells
and through the scaffold by a diaphragm micropump (Fig. 2). Similar to static multiwell
plates, all bioreactors are fluidically isolated and covered with a single lid. Ridges around
the outside of the plate and around each bioreactor reduce the risk of airborne
contamination. The open well design is conducive to manual or automated cell seeding and
fluid handling, and the center-to-center spacing between bioreactors (18 mm) is set to allow
use of multichannel pipettors with alternating tips omitted.
Micropumps are actuated in parallel from pneumatic inputs connected to the perfused
multiwell through a dock (Fig. 1b). Docks are kept in standard CO2 incubators for cell
culture and in sterile hoods for seeding. Pneumatic lines run from the docks to small
electronic controllers outside the sterile environment. The docking design makes handling a
perfused multiwell similar to handling a standard tissue culture plate. Additionally, no
electronics are contained in the perfused multiwell.
The scaffold provides the 3D physical support for cell attachment and tissue formation. Its
design principles are constrained by several requirements that have been discussed
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previously.8 In the perfused multiwell described herein, the scaffold is a circular ECM-
coated polymer wafer with an array of 769 microchannels, each 0.24 mm deep and 0.34 mm
in diameter. It is backed by a filter with 5-µm pores and a filter support. The filter captures
cells in the scaffold immediately after seeding. There is also a filter in the reservoir well.
The presence of filters in both wells prevents the cells from entering the valves and pumps.
Tissue perfusion system
Each bioreactor has an integrated pneumatic micropump comprising a pump chamber, inlet
and outlet valves, and a fluidic capacitor.19, 20 Culture medium is pumped by opening the
inlet valve, filling the pump chamber, reversing the state of the valves, and draining the
pump chamber. Approximately 1 µL is pumped in each cycle. Capacitors convert pulsatile
flow generated by the pump to constant flow through the tissue, thereby eliminating
disruptive oscillatory movement of cells in channels during cell attachment and contributing
to an appropriate physiological flow pattern during long term operation. (Blood flow pulses
due to the heartbeat are damped in the microcirculation in vivo.) The pumping sequence can
be run bi-directionally in order to flow up or down through the scaffold. Flow rate varies
linearly with the pumping frequency up to 1.2 mL min−1 (~25 Hz). The effectiveness of the
capacitor, which increases with increasing flow rate, has been demonstrated for flows as low
as 0.05 mL min−120 The operating range of the pump was targeted to span the range of
physiological and pathological flows observed in vivo. Shear stress in the liver sinusoid in
vivo has been reported between 10 and 50 mPa.21 Based on shear stress calculations
previously reported,8 and a flow rate of 0.25 mL min−1 (0.3 µL min−1 channel−1), we
estimate that shear stress in the scaffold should not exced 30 mPa.
The pumps, valves, and capacitors are made by sandwiching a thin (~25 µm), highly flexible
polyurethane membrane between the top (fluidic) and the bottom (pneumatic) plates. Air
pressure drives the pumps by actuating the membrane. A valve is opened when negative air
pressure pulls the membrane towards the pneumatic plate. Positive air pressure closes the
valve by pressing the membrane against the valve seat in the fluidic plate. The pump
chamber fills when negative pressure is applied to the membrane, and drains in response to
positive air pressure. The fluidic capacitor is created by allowing a section of the membrane
(between the pumps and tissue) to flex. The membrane also provides a partition between the
sterile upper half of the plate (containing the cell cultures) and the non-sterile lower half
(containing the pneumatics).
Pneumatic signals are distributed in parallel to all 12 pumps by three pneumatic lines (Fig.
1b). The lines interface with the controller through a docking station. Connectors in the
docking station have spring-loaded shutoff valves (Colder Products, USA) that
automatically close when the perfused multiwell is unplugged. This prevents discharge of
non-sterile air into the incubator or tissue culture hood and introduction of the humidified air
from the incubator into the pneumatic system. Flexing membranes at the ends of the
pneumatic lines indicate proper connections and functioning pneumatics (Fig. 1a).
Compressed air and vacuum are sourced from laboratory distribution outlets. Air is filtered,
dried with desiccant, and regulated to 40 kPa.
The pumps were designed to be self-priming, bubble-tolerant, and insensitive to changes in
head pressure and pneumatic pressure within their operating range. Reliability of the pumps
was achieved by implementing a number of key design features. For example, sealing
pressure between the plates was maximized by using narrow bosses in the pneumatic plate
around the pump features. Also, a very thin membrane was used to minimize membrane
penetration into the pump features. Dowell pins ensure proper alignment of the pumps. A
channel was cut across the top of the pump chamber to prevent the membrane from
throttling the outlet before all of the fluid is ejected. Similarly, a channel was milled into the
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bottom of the pump chamber to ensure that the membrane does not prematurely seal off the
pneumatic input when vacuum is applied. Additionally, fluidic connections between the
pump features were created by drilling angled channels rather than milling troughs (see Fig.
2). This prevents pneumatic leakage between valves and pumps. Finally, at least one valve is
closed at all times to prevent backflow.
We tested durability of the polyurethane pump membrane by continuously operating 12
bioreactors (eight filled with fluid but without the cells, four dry) at the flow rate of 0.2 mL
min−1 for six months (several hundred thousand cycles). None of the valves or pumps
leaked or failed during this stress test. Thus, these pumps appear to be well-suited for long-
term perfusion of cell cultures.
Fabrication, sterilization and assembly
The majority of parts were fabricated by CNC machining. Polystyrene and polycarbonate
scaffolds were fabricated by microdrilling. The polyether aromatic polyurethane membrane
(ST-625FS, Stevens Urethane, USA, and MT 2001, American Polyfilm, USA) was cut by
laser machining. The 127.8 × 85.5-mm footprint of an assembled perfused multiwell
complies with standard dimensions of the 96-well microplates established by the Society for
Biomolecular Screening.22
Following sterilization, scaffolds were coated with collagen and air-dried. PVDF filters for
the reactor wells were coated in 1% bovine serum albumin. The pneumatic plate and fluidic
plate were assembled with screws fitted with Belleville disc springs to provide constant
sealing pressure on the thin membrane for the duration of an experiment. The bioreactors
were primed with culture medium. After priming, the reactor wells were fitted with O-rings,
filter supports, filters, and scaffolds. Filters were added to the reservoir wells. These
components were secured by tightly-fitting retaining rings. Additional details about
fabrication and sterilization are provided in an electronic supplementary information file.
Liver cell isolation, culture initiation and maintenance
Hepatocyte-enriched populations (“hepatocytes”) were isolated from Fischer rats using a
modification of Seglen’s two-step collagenase perfusion procedure.23 LSEC-enriched non-
parencyhmal cell populations were isolated from enhanced green fluorescent protein
(EGFP)-positive Sprague-Dawley rats. This LSEC-enriched fraction comprises ~80% LSEC
and includes stellate and Kupffer cells.23
Prior to seeding, priming medium in the reservoir and reactor wells was replaced with a
fresh medium. Cells were seeded by pipetting the cell suspension above the scaffold in the
reactor well. Monocultures of hepatocytes were seeded with ~800,000 cells, and since non-
parenchymal cells are smaller than hepatocytes, co-cultures were seeded with ~500,000
hepatocytes and ~500,000 LSEC-enriched population. Immediately after seeding, flow was
initiated downward through the scaffold at 0.25 mL min−1 (~0.3 µL min−1 channel−1) and
culture medium was added to obtain a total volume of ~3 mL. The perfused mltiwell was
then moved inside a humidified 5% CO2 (air balance) incubator maintained at 37 °C.
Cells attach to the scaffold within the first few hours, and, for hepatocyte cultures, result in a
stable population of ~400,000 to 600,000 cells (as measured by total protein bicinchoninic
acid (BCA) assay). This is consistent with typical plating efficiencies in 2D cultures. After 8
hours the direction of flow was reversed to dislodge dead cells and debris. Flow up through
the scaffold at 0.25 mL min−1 was maintained throughout the remaining culture period.
Hepatocyte cultures were initiated and maintained in serum-free hepatocyte growth medium
(HGM).23 Co-cultures of hepatocytes combined with the LSEC-enriched population were
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initiated with a mixture containing HGM and endothelial growth medium in a 1:1 volume
ratio for the first 24 hours, and then maintained in HGM. Culture medium was changed
every 48 hours during long-term culture. During each exchange, flow was paused and
approximately 80% of the medium was replaced. The remaining medium kept the cells
submerged and the pumps primed.
Cell viability was assessed with the live/dead viability kit. Synthesis of albumin was
demonstrated by staining with an antibody for rat albumin (AbCam, USA), and DRAQ-5
was used to stain cell nuclei (Biostatus Limited, USA). Antibodies for SE-1 were obtained
from IBL America, USA. More details about the cells and culture medium are provided in
an electronic supplementary information file.
Oxygen sensors
Oxygen measurements were performed using custom fiber optic probes mounted in a
custom lid. Oxygen is detected using a 2-mm diameter ruthenium-based sensing layer
(PreSens, Germany), where luminescence of ruthenium molecules in an excited state is
quenched by collisions with molecular oxygen. The probes are connected to a 4-channel
fiber optic meter (OXY-4 by PreSens, Germany) and luminescence decay time is measured
by the phase modulation technique.
The custom lid contains 24 ports centered on each well in the plate. Each port contains a
connector and an O-ring used to vertically position the oxygen probe. All probes are
submerged to a depth of ~2 mm above the scaffold. Optical fibers coming vertically out
from the lid are supported by a second platform ~10 cm above the lid. The second platform
holds unions that connect the probes with the optical fibers coming from the OXY-4 meter.
This arrangement facilitates adjustment of the probe depth and allows quick connections
between the probes and the optical fibers. Prior to experiments, oxygen sensors are
calibrated with two calibration standards. Sterilization of the probes was verified not to
interfere with the calibration.
Computational simulation of oxygen transfer
During bioreactor operation, cell culture medium circulates between the reactor and
reservoir. Oxygen consumed by cells in the scaffold is replenished by diffusive and
convective flux from the air-liquid interface. This generates a multidimensional pattern of
oxygen concentration in the bioreactor. To simulate how operating parameters such as
medium flow rate and total medium volume influence oxygen transport and ensuing
concentrations of oxygen at the upstream side of the tissue, and to predict appropriate
locations for measuring oxygen concentration, we developed a model of oxygen transport
(with fixed inlet concentration) and applied it to predict oxygen concentration profiles in the
reactor. Following the guidance of the model, we placed the oxygen probes into the
bioreactor with cells and performed several measurements of oxygen concentration. Using
the experimental measurements, we developed a model of oxygen consumption by liver
tissue maintained in the reactor and then coupled it with the model of oxygen transport.
Oxygen transport and consumption were simulated with a 3D finite differences model. To
understand the model development, consider the path of fluid flowing clockwise in Fig. 2,
starting at the bottom of the reservoir. Fluid velocity exiting the reservoir is constant due to a
high-impedance filter; however, the oxygen concentration varies with position. As fluid
passes through the pump we assume it is completely mixed and oxygen transfer into culture
medium through the low-permeability polyurethane membrane can be neglected. We
calculate the mixed concentration from flux across the reservoir filter. Thus, fluid enters the
lower face of the scaffold (i.e., scaffold inlet) at a uniform concentration Cin. Fluid velocity
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entering the scaffold is also uniform due to a filter below the scaffold. Oxygen is consumed
by the cells as fluid passes upward through the scaffold. Experimentally, no significant
differences are observed in the cell distributions at different regions of the scaffold, hence, it
is reasonable to assume that concentration exiting the scaffold Cout is constant everywhere
on the upper face of the scaffold. As fluid progresses upward, velocity and concentration
profiles evolve in response to the boundary conditions on the walls, convection, and
diffusion from the gas/liquid interface. Fluid then flows across an open channel into the
reservoir generating a non-uniform oxygen concentration profile in the reservoir, where the
cycle is completed.
The control volume for the model extends from the air-liquid interface down to the scaffold
in the reactor well and the filter in the reservoir well. Figure 3 shows the results of a model
calculation for a flow rate of 0.25 mL min−1 upward through the scaffold and Cout of 50 µM,
a concentration in the range of perivenous blood plasma oxygen concentration, hence a
reasonable value to expect experimentally. The color of fluid below the scaffold represents
the concentration after mixing occurs in the pump. The oxygen concentration profile
indicates that probes placed in the center of the wells ~2 mm above the scaffold measure Cin
and Cout with an estimated error of less than 5% (see below in Results and discussion).
When the flow is reversed, the positions of Cin and Cout are likewise reversed, and the
ensuing concentration profiles mirror those in Fig. 3. The appropriate location of probe
placement remains the same. Note that oxygen concentration profiles can be non-
dimentionalized and thus are independent of the value of Cout specified. Therefore, the
appropriate probe location is independent of outlet concentrations.
The oxygen transport model was based upon existing MATLAB code24 with an added mass
transport equation. The model first calculates a flow profile from Navier-Stokes and
continuity equations and iterates solutions until the profile stabilizes. Next it solves for
oxygen concentration using convection-diffusion equations, and concentration profiles are
iterated until steady state. Details of the geometry, boundary conditions, and code elements
are provided in an electronic supplementary information file.
Results and discussion
Measured values of dissolved oxygen indicate physiologically relevant oxygen gradients
across the tissue
Measured values of dissolved oxygen in the reactor and reservoir wells during the first 20
hours of culture are shown in Fig. 4a. The culture medium is air-saturated at the time cells
are seeded in the bioreactor. After flow is initiated, cellular oxygen consumption causes the
oxygen concentration to decline for several hours until equilibrium is reached between
cellular consumption and oxygen transport at the air-liquid interface. During the first 8
hours, a flow rate of 0.25 mL min−1 was maintained in a downward direction through the
scaffold, and Cout reached a steady state value of ~60 µM with a corresponding Cin value of
145 µM. Because the predicted oxygen concentrations are the mirror image of those shown
in Fig. 3, the oxygen concentration varies along the surface of the scaffold when the flow is
in the downward direction. The model predicts that the oxygen concentration in the medium
entering the scaffold ranges from ~90 µM at the innermost location to ~190 µM at the outer
edge during the first 8 hours of operation, when flow is in the downward direction.
After 8 hours the flow direction was reversed while maintaining a constant flow rate.
Immediately following the flow reversal, oxygen-depleted medium below the scaffold and
in the reservoir was passed directly back through the cells. During this time (~10 minutes
with the flow of 0.25 mL min−1) the cells were exposed to relatively low inlet
concentrations, and a concomitant drop of ~25% in the outlet concentration was observed
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with a longer transient (~2 hr). When the regime of stable concentrations is reached, the
concentration of oxygen entering the scaffold is constant and uniform across all channels in
the scaffold. Due to oxygen consumption by the cells, there are gradients of oxygen in the
tissue.
To determine a range of acceptable operating parameters, and to estimate cellular oxygen
consumption rates in this perfused culture, inlet and outlet oxygen concentrations were
measured as a function of flow rate. Following the initial 20 hours plotted in Fig. 4a, flow
rate was incrementally changed as shown in Fig. 4b. The inlet oxygen concentration in this
experiment fluctuates modestly around ~145 µM. Although this concentration is higher than
values reported for the human in vivo periportal (sinusoidal entry) region (84–91 µM), it is
within arterial blood oxygen concentration ranges (104–146 µM) and below hyperoxic
concentration levels.25 Oxygen concentration downstream of the tissue increases with
increasing flow rate, from ~19 µM to ~125 µM. In human, the reported in vivo perivenous
(sinusoidal exit) region dissolved free oxygen concentration is 42–49 µM.25 A tissue outlet
concentration of ~50 µM is observed at a flow rate of 0.25 mL min−1, hence, this flow rate
provides a reasonable approximation of physiological gradients. Gradients are steeper than
those in vivo because culture medium does not contain hemoglobin, which serves as a depot
of oxygen.
Oxygen consumption rates within the perfused tissue
Oxygen consumption in intact liver and whole liver cells is regulated by oxygen
concentration well above the Michaelis constant Km for mitochondrial enzymes,26, 27
resulting in an apparent Km of 175 µM reported for perfused rat liver.2, 3 Oxygen
consumption rates and concentrations of metabolic enzymes vary significantly within the
sinusoid in vivo.25 Along the direction of flow, oxygen consumption decreases two-fold
from periportal to pericentral regions in perfused liver. The system described here exhibits
similarities including gradients of oxygen along the flow path. Additionally, oxygen
gradients inherently exist between the main conduits for convective flow through the tissue
and the surrounding 3D tissue structures. Thus the average oxygen concentration in the
tissue at the exit is lower than the measured value of Cout, because Cout represents the
oxygen concentration in the bulk fluid. This tends to elevate the apparent Km. Given these
considerations, we model oxygen uptake by the cells in the scaffold as a first-order reaction
and approximate the outlet oxygen concentration by equation
(1)
where Vmax is the maximum oxygen consumption rate and tr is the residence time of
medium in the scaffold. Residence time is a function of flow rate, tissue density, and tissue
morphology inside the scaffold. Since we seed the cells at approximately a constant density
in each scaffold and the tissue develops a similar morphology across experiments, we
combine the portion of tr that relates to tissue density and morphology with Vmax/Km and
report a system-specific rate constant K and oxygen consumption equation
(2)
where Q is the flow rate through the scaffold. Using Eq. 2 and the data in Fig. 4b, we found
K for this experiment to be 0.24 ± 0.02 mL min−1. The low standard deviation further
supports using a first order model. To verify the rate constant K, we performed seven
replicates (three monocultures and four co-cultures) with cells from four different isolations.
The constant was calculated from the stabilized oxygen concentrations measured 18 hours
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after cell culture initiation. After removing the highest and lowest outliers, five data sets
yielded rate constant K = 0.27 ± 0.03 mL min−1.
Total oxygen consumption throughout the tissue is found by multiplying the drop in
concentration by the flow rate and dividing by the total tissue mass. Using the average tissue
mass per scaffold of 0.5 mg protein, and inlet and outlet concentrations of 145 µM and 50
µM, respectively (for a flow rate of 0.25 mL min−1), we find the total oxygen consumption
rate across the scaffold to be comparable to consumption rates for isolated hepatocytes and
perfused rat livers (see Table 1). We can also estimate local oxygen consumption rates by
multiplying the rate constant K by the local oxygen concentration and normalizing by the
total cell mass in the scaffold. The values we estimate for consumption at the tissue inlet are
most likely elevated because they are based on a first order approximation, which doesn’t
inherently limit the maximum consumption rate. Our estimate for consumption at the tissue
outlet is also likely higher than we could expect in the actual tissue. Since oxygen
concentration deep in the tissue will be lower than the bulk concentration we measure above
the scaffold, the consumption rate deep in the tissue should also be lower than is reported in
Table 1.
Using the above rate constant K, we combined Eq. 2 with the oxygen transfer model to
simulate oxygen concentrations in the bioreactor. Modeled concentrations at the inlet
(entering the tissue), outlet (exiting the tissue) and the location of the probe are plotted in
Fig. 5 and compared to measured values. In the experiments the bioreactor contained ~3 mL
of cell culture medium, filling the wells to ~1 mm above bottom of the surface channel. Due
to a meniscus, the depth of medium in the middle of the channel is slightly less than 1 mm
while the depth along the wall is higher. For this reason, simulations in Fig. 5 were
performed for the channel depth of 0.5 and 1 mm. It can be seen that the depth of culture
medium in the bioreactor has a significant impact on oxygen concentrations, and that the
model for a depth of 0.5 mm is in better agreement with the experimental data. The model
predicts that the measured value by the oxygen probe underestimates inlet oxygen
concentration by less than 5% in the investigated range of flow rates.
Since each channel in the scaffold represents an individual unit of tissue, it is desirable to
define rate constant K ̅ on a per-channel basis (K = 0.27 mL min−1 per 769 channels yields K̅
= 0.35 µL min−1 channel−1). When K̅ and flow per channel Q ̅ are used, Eq. 2 scales to
scaffolds with different numbers of channels.
Assessment of phenotype and function of the tissue cultured in the perfused multiwell
Several assays were performed on the liver cells cultured in the perfused multiwell to asses
phenotype and function. The viability of hepatocytes was determined by a fluorescent live/
dead assay. Fig. 6a indicates that liver cells cultured in the perfused multiwell for seven days
are predominantly viable, although there are few non-viable cells adhering to the top surface
of the scaffold. To evaluate liver-specific function, we stained the tissue with anti-rat
albumin antibody. Fig. 6b demonstrates retention of this hepatocyte-specific functional
marker after seven days of culture.
Liver tissue engineering models are increasingly moving from hepatocyte-only cultures to
co-cultures containing non-parenchymal cells (NPCs), such as LSECs and stellate cells in
order to create more physiologically relevant systems.32, 33 However, LSECs are notoriously
challenging to culture under standard in vitro conditions. When cultured alone, LSECs
showed signs of dedifferentiation after 1–3 days of static culture on most investigated
ECMs.34 Using medium conditioned with hepatocytes, differentiated LSECs were
maintained up to 6 days.35 LSECs co-cultured with hepatocytes on decellularized liver-
derived connective tissue matrix showed highly fenestrated phenotype (the presence of
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fenestrations is considered a reliable morphological marker of LSECs) during the first 3
days of culture but showed a decline in the maintenance of fenestrated phenotype after 7
days of culture.34 An early prototype single-unit perfused bioreactor that had medium
flowing through both the tissue in the scaffold and above the tissue in the direction parallel
to the scaffold was shown to maintain expression of the functional marker for LSECs, SE-1,
for a significantly longer time period than commonly reported in literature.23 To
demonstrate suitability of the perfused multiwell (with flow through the tissue) for long-
term co-cultures, we seeded it with rat non-parenchymal cells and hepatocytes and followed
the cultures for two weeks. At the end of these experiments, the tissue samples were fixed
with 4% paraformaldehyde and immunostained for various functional markers of NPCs.
Confocal microscopy of the immunostained tissue demonstrated that LSECs retain
expression of the functional marker SE-1 as late as 13 days post-seeding (Fig. 6c). The
preservation of the LSEC phenotype even in the absence of serum or exogenous supportive
endothelial growth factors like vascular endothelial growth factor (VEGF) in the culture
medium typically needed for LSEC survival may point to the role of the 3D cell-cell
interactions and flow in the perfused multiwell. Retention of the endothelial phenotype was
seen to be dependent on the flow rate and the oxygen concentration in the perfused
multiwell.36 Similar staining for the functional markers with the antibodies ED-2 and GFAP
at 13 days also indicated the presence of Kupffer cells and stellate cells, respectively,36
thereby establishing the system as being conducive for the culture of various non-
parenchymal cells in co-cultures with hepatocytes.
Conclusions
An array of bioreactors that foster maintenance of 3D liver tissue under constant
microperfusion has been integrated into a multiwell plate format. The bioreactors have open
wells, built-in micropumps, and the perfused multiwell plate employs a docking design that
facilitates handling and integration into conventional incubation and assay tools. A model of
oxygen consumption and transport in the circulating culture medium was used to predict
appropriate operating parameters for liver cell cultures. Model predictions were validated by
measuring oxygen concentrations in cultures of primary rat hepatocytes as a function time
and flow. From the measurements, we determined that consumption of oxygen by tissue can
be characterized with a system specific first order reaction constant K = 0.27 ± 0.03 mL
min−1. Considering physiological values, experimental measurements showed that tissue in
the scaffold was adequately oxygenated for flow rates above 0.25 mL min−1. Consumption
of oxygen by the cells in the scaffold was similar to oxygen consumption in perfused rat
livers.
After seven days in culture, the viability of hepatocytes was determined by the live/dead
staining and liver-specific function was demonstrated by immunostaining with a rat albumin
antibody. To demonstrate suitability of the perfused multiwell for long-term tissue culture,
we seeded it with LSECs and rat hepatocytes and showed that LSECs, known to lose
differentiated phenotype under static culture conditions, maintain expression of the
functional marker SE-1 throughout 13 days of co-culture with hepatocytes.
The higher throughput capability of the perfused 3D liver multiwell is beneficial for
conducting assays for liver toxicology and metabolism and can be used to model hepatic
disorders, cancer, and other human diseases. Although we described the design and function
of an array of 24 wells, the concept is scalable to a plate with a higher number of wells, such
as a 96-well plate. This format is desirable for reducing cell quantities per well (e.g., when
using human cells) or increasing throughput. In the reported experiments, we chose rigid
polystyrene and polycarbonate scaffolds coated with collagen, but the design provides
flexibility for using scaffolds made from a wide variety of different materials such as protein
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matrices, hydrogels, fibers or other classes of material. Fasteners such as screws and
retaining rings were used on the perfused multiwell for prototyping reasons. They facilitate
testing a large spectrum of membrane and scaffold materials without the difficulties
associated with joining hard-to-bond or incompatible materials. For larger scale deployment,
the perfused multiwell plate can be made disposable by employing, for example, injection
molding and bonding techniques. Cultures of cells from other organs and stem cell cultures
also benefit from 3D environments and tissue perfusion.37 Although we designed the
perfused multiwell primarily for the culture of liver cells, it can be used for perfusion culture
of other high metabolically active cell types such as kidney, heart, or brain cells.
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Fig. 1.
Photographs of a perfused multiwell with an array of 12 bioreactors. The size of the
assembled multiwell plate is ~127.8 × 85.5 × 34 mm. The top view (a) includes inserted
photographs of a bioreactor and a scaffold. The size of the white bar in the scaffold
photograph is 300 µm. The bottom view (b) of a partially docked perfused multiwell shows
the built-in connectors and pneumatic lines distributing positive and negative air pressure to
individual valves and pump chambers.
Domansky et al. Page 12
Lab Chip. Author manuscript; available in PMC 2014 April 02.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 2.
A schematic cross-section of a bioreactor (section A-A’ from Fig. 1a). Maintenance and
post-seeding flow directions are indicated by arrows (1) and (2), respectively. Diameter of
the reactor and reservoir well is 15 mm. Centers of the wells are 20 mm apart. Diameter of
the scaffold is 14.9 mm. When there are 3 mL of culture medium in a bioreactor (a typical
total volume), top of the scaffold is under ~7 mm of fluid. The valves, the pump chamber,
and other features are not drawn to scale.
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Fig. 3.
A simulation of oxygen transport. The control volume is marked by a dashed line. Oxygen
probes are sketched as black rectangles in the middle of the reactor and reservoir wells. The
depth of culture medium in the channel was 1 mm corresponding to total volume of ~3 mL.
The flow rate was 0.25 mL min−1
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Fig. 4.
Measured concentration of dissolved oxygen in reservoir and reactor wells seeded with rat
hepatocytes: (a) As a function of time post seeding with a flow rate of 0.25 mL min−1 and a
sampling rate of 0.2 measurements per minute. (b) As a function of flow rate (immediately
following the time course measurement) with a sampling rate of 1 measurement per minute.
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Fig. 5.
Measured and modeled inlet and outlet oxygen concentrations as a function of flow for two
depths of cell culture medium in the channel. The figure also shows modeled oxygen
concentration at the oxygen probe location.
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Fig. 6.
(a) Cell viability assay of rat liver cells cultured for seven days in the perfused multiwell.
The image shows multiple channels in a scaffold. Live cells are stained green with calcein
AM while dead cells are stained red with ethidium homodimer-1. The areas occupied by the
cells are bright green and areas without cells appear dark green or black. (b) Immunostaining
of rat liver cells cultured in the perfused multiwell 7 days post seeding demonstrating
retention of the hepatocyte-specific functional marker albumin (green). Staining was
preformed with rat albumin antibody. This image shows a single channel with its boundary
highlighted by a white dash line. (c) Image of rat hepatocytes and sinusoidal endothelial
cells cultured in the perfused multiwell plate day 13 post seeding. Nuclei are stained blue
with DRAQ 5, non-parenchymal cells express green fluorescent protein (GFP), and the
functional marker for sinusoidal endothelial cells (SE-1) is stained red.
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Table 1
Oxygen consumption rates in the bioreactor compared with oxygen consumption in isolated hepatocytes and a
perfused rat liver. To convert to equivalent units in all systems, we assumed 110 × 106 cells per gram of
liver28 and 1 mg protein per 106 cells (observation from our laboratory).
µmol hour−1 mg protein−1 Periportal or
tissue inlet
Pericentral or
tissue outlet
Total
Perfused multiwell plate 4.7 1.8 2.6
Isolated hepatocytes29 2.5
Perfused rat liver30 1.8
Perfused rat liver31 1.2 0.6 1.0
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